RecruitingNCT03296826

Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2


Sponsor

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Enrollment

600 participants

Start Date

Nov 8, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

To determine the incidence and risk factors in the development of ovarian, fallopian tube, and peritoneal cancers in Japanese women carrying Breast Cancer Susceptibility Gene (BRCA)1/2 variants.


Eligibility

Sex: FEMALEMin Age: 20 Years

Plain Language Summary

Simplified for easier understanding

This study is tracking women who carry BRCA1 or BRCA2 gene mutations — genes linked to higher risk of ovarian and breast cancer — to better understand their health outcomes over time. **You may be eligible if...** - You are a woman with a BRCA1 or BRCA2 gene mutation (or both), or an uncertain gene change called a variant of uncertain significance (VUS) - You have already received genetic counseling at a medical facility - You are 20 years old or older - You are willing to give written consent to participate **You may NOT be eligible if...** - You currently have ovarian or fallopian tube cancer - You have a past diagnosis of ovarian, fallopian tube, or peritoneal (abdominal lining) cancer - The study doctor decides participation is not appropriate for you Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Okayama University

Okayama, Japan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03296826


Related Trials